Riboflavin carrier protein-targeted fluorescent USPIO for the assessment of vascular metabolism in tumors

Biomaterials

Volumn 33, Issue 34, 2012, Pages 8822-8829

  Jayapaul, Jabadurai ^a,b   Arns, Susanne ^a   Lederle, Wiltrud ^a   Lammers, Twan ^a   Comba, Peter ^b   Gätjens, Jessica ^a   Kiessling, Fabian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endothelium; Flavin adenine dinucleotide; Iron oxide nanoparticles; Magnetic resonance imaging; Molecular imaging; Riboflavin carrier protein

Indexed keywords

CANCER CELLS; CARRIER PROTEINS; CELLULAR GROWTH; COATING METHODS; ENDOTHELIUM; FLAVIN ADENINE DINUCLEOTIDE; FLAVIN MONONUCLEOTIDES; FTIR; IN-VITRO ANALYSIS; IN-VIVO; INTRACELLULAR TRANSPORT; IRON OXIDE NANOPARTICLE; NON-POLYMERIC; PHYSICOCHEMICAL PROPERTY; TUMOR METABOLISMS; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

BIOCOMPATIBILITY; BLOOD VESSELS; ENDOTHELIAL CELLS; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; MAGNETIC RESONANCE IMAGING; METABOLISM; METAL NANOPARTICLES; MOLECULAR IMAGING; PHYSIOLOGY; SUPERPARAMAGNETISM;

TUMORS;

FLAVINE ADENINE NUCLEOTIDE; RIBOFLAVIN BINDING PROTEIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; CELL GROWTH; CELL STRAIN LNCAP; CELL VIABILITY; CHEMICAL COMPOSITION; CYTOTOXICITY; ELECTROPHORETIC MOBILITY; EXTRAVASCULAR SPACE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; METABOLISM; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON TRANSPORT; SURFACE CHARGE; TUMOR METABOLISM; ZETA POTENTIAL;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DEXTRANS; FLAVIN-ADENINE DINUCLEOTIDE; FLUORESCENT DYES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, NUDE; MOLECULAR IMAGING; NANOPARTICLES; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84866865581     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.036     Document Type: Article

References (26)

1. Mason C.W., D'Souza V.M., Bareford L.M., Phelps M.A., Ray A., Swaan P.W. Recognition, co-internalization, and recycling of an avian riboflavin carrier protein in human placental trophoblasts. J Pharmacol Exp Ther 2006, 317(2):465-472.
2. Kirkpatrick N.D., Zou C., Brewer M.A., Brands W.R., Drezek R.A., Utzinger U. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring. Photochem Photobiol 2005, 81(1):125-134.
3. Ostrander J.H., McMahon C.M., Lem S., Millon S.R., Brown J.Q., Seewaldt V.L., et al. Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res 2010, 70(11):4759-4766.
4. Mujat C., Greiner C., Baldwin A., Levitt J.M., Tian F., Stucenski L.A., et al. Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells. Int J Cancer 2008, 122(2):363-371.
5. Skala M.C., Riching K.M., Gendron-Fitzpatrick A., Eickhoff J., Eliceiri K.W., White J.G., et al. In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. Proc Natl Acad Sci USA 2007, 104(49):19494-19499.
6. Foraker A.B., Khantwal C.M., Swaan P.W. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv Drug Deliv Rev 2003, 55(11):1467-1483.
7. Huang S.N., Swaan P.W. Involvement of a receptor-mediated component in cellular translocation of riboflavin. J Pharmacol Exp Ther 2000, 294(1):117-125.
8. Huang S.N., Phelps M.A., Swaan P.W. Involvement of endocytic organelles in the subcellular trafficking and localization of riboflavin. J Pharmacol Exp Ther 2003, 306(2):681-687.
9. Karande A.A., Sridhar L., Gopinath K.S., Adiga P.R. Riboflavin carrier protein: a serum and tissue marker for breast carcinoma. Int J Cancer 2001, 95(5):277-281.
10. Johnson T., Ouhtit A., Gaur R., Fernando A., Schwarzenberger P., Su J., et al. Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer. Front Biosci 2009, 14:3634-3640.
11. Bareford L.M., Phelps M.A., Foraker A.B., Swaan P.W. Intracellular processing of riboflavin in human breast cancer cells. Mol Pharmacol 2008, 5(5):839-848.
12. Holladay S.R., Yang Z., Kennedy M.D., Leamon C.P., Lee R.J., Jayamani M., et al. Riboflavin-mediated delivery of a macromolecule into cultured human cells. Biochim Biophys Acta 1999, 1426(1):195-204.
13. Plantinga A., Witte A., Li M.H., Harmon A., Choi S.K., Banaszak Holl M.M., et al. Bioanalytical screening of riboflavin antagonists for targeted drug delivery-a thermodynamic and kinetic study. ACS Med Chem Lett 2011, 2(5):363-367.
14. Thomas T.P., Choi S.K., Li M.H., Kotlyar A., Baker J.R. Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery. Bioorg Med Chem Lett 2010, 20(17):5191-5194.
15. Witte A.B., Timmer C.M., Gam J.J., Choi S.K., Banaszak Holl M.M., Orr B.G., et al. Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery. Biomacromolecules 2012, 13(2):507-516.
16. Roming M., Luensdorf H., Dittmar K.E.J., Feldmann C. ZrO(HPO(4))(1-x)(FMN)(x): quick and easy synthesis of a nanoscale luminescent biomarker. Angew Chem Int Ed Engl 2010, 49(3):632-637.
17. Jayapaul J., Hodenius M., Arns S., Lederle W., Lammers T., Comba P., et al. FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells. Biomaterials 2011, 32(25):5863-5871.
18. Yu F.X., Goh S.R., Dai R.P., Luo Y. Adenosine-containing molecules amplify glucose signaling and enhance Txnip expression. Mol Endocrinol 2009, 23(6):932-942.
19. Bumb A., Brechbiel M.W., Choyke P.L., Fugger L., Eggeman A., Prabhakaran D., et al. Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology 2008, 19(33):335601.
20. Jander G., Jahr K. Massanalyse 2009, p. 219-21. 17 ed.
21. Bashir W.A. Photometric determination of iron (III). Microchem J 1981, 26(4):477-480.
22. Umekita Y., Hiipakka R.A., Kokontis J.M., Liao S. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci U S A 1996, 93(21):11802-11807.
23. Chowdhury M.H., Lakowicz J.R., Ray K. Ensemble and single molecule studies on the use of metallic nanostructures to enhance the intrinsic emission of enzyme cofactors. J Phys Chem C Nanomater Interfaces 2011, 115(15):7298-7308.
24. Becvar J., Palmer G. The binding of flavin derivatives to the riboflavin-binding protein of egg white. A kinetic and thermodynamic study. J Biol Chem 1982, 257(10):5607-5617.
25. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010, 188(6):759-768.
26. Reimer P., Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003, 13(6):1266-1276.